Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

A comprehensive assessment using COPD assessment test scoring and modified Medical Research Council dyspnea scoring is necessary for personalized therapy for COPD patients

Authors Teramoto S, Inui T, Hizawa N

Received 15 August 2015

Accepted for publication 7 September 2015

Published 15 October 2015 Volume 2015:10(1) Pages 2203—2206

DOI https://doi.org/10.2147/COPD.S94509

Checked for plagiarism Yes

Editor who approved publication: Dr Richard Russell

Shinji Teramoto,1 Toshihide Inui,2 Nobuyuki Hizawa3

1Department of Pulmonary Medicine, Hitachinaka Medical Education and Research Center, University of Tsukuba, Ibaraki, Japan; 2Department of Pulmonary Medicine, Hitachinaka General Hospital, Hitachi Ltd, Ibaraki, Japan; 3Department of Pulmonary Medicine, Graduate School of Comprehensive Human Science, University of Tsukuba, Ibaraki, Japan

In a recent issue of the International Journal of COPD, Rhee et al1 have demonstrated considerable discrepancies between modified Medical Research Council (mMRC) dyspnea scoring and COPD assessment test (CAT) scoring in patients with COPD. The current data are also supported by the findings described in another article, which indicates that more than 50% of COPD patients show discrepancies between the severity of CAT scores and that of mMRC scores in the real world.


Read the original paper

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

COPD exacerbation frequency and its association with health care resource utilization and costs

Dhamane AD, Moretz C, Zhou Y, Burslem K, Saverno K, Jain G, Renda A, Kaila S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2609-2618

Published Date: 3 December 2015

Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: a randomized clinical trial of nonpharmacological treatment

Baldi S, Pinna GD, Bruschi C, Caldara F, Maestri R, Dacosto E, Rezzani A, Popovich E, Bellinzona E, Crotti P, Montemartini S, Fracchia C

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2235-2248

Published Date: 23 October 2015

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD

Rhee CK, Kim JW, Hwang YI, Lee JH, Jung KS, Lee MG, Yoo KH, Lee SH, Shin KC, Yoon HK

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1623-1631

Published Date: 12 August 2015

Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients

Nascimento ESP, Sampaio LMM, Peixoto-Souza FS, Dias FD, Gomes ELFD, Greiffo FR, Ligeiro de Oliveira AP, Stirbulov R, Vieira RP, Costa D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:645-653

Published Date: 23 March 2015

Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure

Ostergaard L, Rudiger A, Wellmann S, Gammella E, Beck-Schimmer B, Struck J, Maggiorini M, Gassmann M

Hypoxia 2014, 2:143-151

Published Date: 11 September 2014